Cancer Screen Week 2020

Cancer Screen WeekAccording to the American Cancer Society, almost 607,000 people are expected to die from cancer in 2020. Regular screening can help find certain cancers early when they are most likely to be treated successfully. This Cancer Screen Week (Dec 7-11), help us raise awareness and learn more of the potentially lifesaving benefits of

National Brain Tumor Awareness Month

May is National Brain Tumor Awareness Month.  Driven by advancement in research, surgical techniques, genetic discoveries, and much more, it has never been a better time to take action on brain tumors. The National Brain Tumor Society (NBTS), an organization whose mission is to unrelentingly invest in, mobilize, and unite our community to discover a

Hypofractionated Radiation Therapy for Prostate Cancer

As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments.  Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations

New Jersey CyberKnife Recognized for RSSearch® Patient Registry Contributions

New Jersey CyberKnife at Community Medical Center is recognized by RSSearch® by The Radiosurgery Society as the second-largest contributor in the world for 2019. Serving in the community hospital world-renown for its radiosurgery program, Dr. Iyers and Dr. D’Ambrosio have contributed a substantial amount of potentially groundbreaking treatment data and patient information to foster new

Prostate Cancer Treatment and Sexual Function

When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration.  While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them.  That choice is often based on treatment outcomes and side effects, and

Studies Show CyberKnife Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions

Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer.  The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in

Educational and Myth-Busting Dinner at The Pines

New Jersey CyberKnife rounded out the month of August by partnering with The Pines, a senior living community located in Whiting, New Jersey, to sponsor an educational dinner program for residents. New Jersey CyberKnife Medical Director, David D’Ambrosio, M.D., and Eric Lehnes, M.D., an OB/GYN physician affiliated Ocean Gynecological & Obstetrical Associates, spoke to residents

Cancer Care is a Team Effort

When it comes to fighting cancer, it takes a team of people.  Treatment at our center means that you are not alone in the fight. Cancer treatments are rapidly advancing and having a research focused team of radiation oncologists enables us to bring you the most up-to-date approaches to fighting your specific cancer. In cancer

Celebrating Cancer Survivors

June is National Cancer Survivor Month, a time to celebrate and recognize cancer survivors, inspire those recently diagnosed, and, most importantly, to celebrate life. During the month, cancer survivors and supporters in communities around the world unite to celebrate life and raise awareness of the challenges faced by cancer survivors. It is a time for

Accredited Breast Care

When it comes to caring for and treating breast cancer patients, New Jersey CyberKnife is proud to be a part of the J. Phillip Citta Regional Cancer Center, whose Breast Center is the only NAPBC-Accredited Program in Ocean and Atlantic counties. The Breast Center at the J. Phillip Citta Regional Cancer Center at Community Medical

The Role of Nutrition in Cancer Care

March is National Nutrition Month.  A nutrition education and information campaign, created by the Academy of Nutrition and Dietetics, that focuses on the importance of making informed food choices and developing sound eating and physical activity habits. We all know that good nutrition is important for good health.  This statement is even truer for cancer

Study Finds SBRT Better than Surgery in Post-Treatment Lung Cancer Survival

In a recent new study published online in the Journal of Clinical Oncology, a peer-reviewed medical journal published by the American Society of Clinical Oncology, patients with non-small cell lung cancer who underwent stereotactic body radiation therapy (SBRT) had a better post-treatment survival rate than those who received surgery. The gold standard for the treatment

Preventing Cancer

February is National Cancer Prevention Month.  If your New Year’s resolution to get healthy is already losing steam, now is a perfect time to give yourself a second chance.  Renew your efforts to make healthier choices by learning what you can do to help reduce your cancer risk. Research has shown that more than half

National Radon Action Month

Radon is the leading cause of lung cancer deaths among nonsmokers in America and claims the lives of about 21,000 Americans each year.  In fact, the EPA and the U.S. Surgeon General urge all Americans to protect their health by testing their homes, schools, and other buildings for radon. Radon is an invisible, odorless, tasteless

Diane's Story: Treating Breast Cancer with CyberKnife Technology

The American Cancer Society reports that there will be almost a quarter of a million women diagnosed with breast cancer in the United States this year and over 8,000 of those cases will be in New Jersey. Even though breast cancer is the most frequently diagnosed cancer in U.S. women, survivorship rates continue to steadily

New Jersey CyberKnife Hosts Women’s Health Night

New Jersey CyberKnife and Community Medical Center recently hosted a Women’s Health Night.  The free community was held at Harrogate Senior Living in Lakewood, New Jersey and included dinner and several speakers discussing topics related to women’s health including preventative care, screening recommendations, and much more. The speakers featured at the event were David D’Ambrosio

Women's Health Night

New Jersey CyberKnife and Community Medical Center invite you to join them for Women’s Health Night on Tuesday, November 28th.  This free community event will feature presentations on women’s health and preventative care, screening recommendations, and much more.  Join us and bring a woman you care about in your life to this informative event!  

Targeted Radiotherapy Limits Side Effects of Breast Cancer Treatment

According to study results published in The Lancet, a weekly peer-reviewed general medical journal, breast cancer patients who have radiotherapy targeted at the original tumor site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return. The researchers at 30 radiotherapy

New Data Supports Use of SBRT in Elderly Patients with Early-Stage Lung Cancer

New data from a recent study titled “Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer” demonstrated that stereotactic body radiation therapy (SBRT) is a safe treatment option for early-stage lung cancer patients aged 80 or older. The study, which was published in The Red Journal, the official journal

ASTRO Issues Guidelines for Using High-dose Focused Radiation in Early-stage Lung Cancer

The American Society for Radiation Oncology (ASTRO), the premier radiation oncology society in the world for health care professionals who specialize in treating patients with radiation therapies, has released new guidelines for treating inoperable lung cancer patients with stereotactic body radiation therapy (SBRT). The report, “Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung

New Jersey CyberKnife Accepting Patients for Partial Breast Irradiation Study

According to the American Cancer Society, about 1 in 8 women in the U.S. will develop breast cancer during their lifetime. Survival rates from breast cancer have been increasing since about 1989, with larger increases in women younger than 50.  These increases are believed to be the result of earlier detection through screening and increased

To Screen or Not to Screen for Lung Cancer?

A new study in CHEST, a peer-reviewed medical journal covering chest diseases and related issues, determined that a structured prescreening counseling and shared decision-making visit with healthcare professionals leads to a better understanding of the benefits and risks, as well as the eligibility criteria, of lung cancer screening using a low-dose CT scan. This is

American Urological Association, American Society for Radiation Oncology, and the Society of Urologic Oncology Release Joint Prostate Cancer Guidelines

Last week, the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) released collaborative clinical guidelines for managing localized prostate cancer which offers a framework for shared decision-making between physicians and patients.  Through this collaboration, the committee provided guidance on active surveillance and on which treatments

Radiosurgery Society Study Examines Stereotactic Body Radiation Therapy Outcomes in the Treatment of Lung Metastases

The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, recently published a study using data from its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection from patients treated with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The study, titled “Lung

New Jersey CyberKnife lung cancer radio spot

Please take a moment and listen to New Jersey CyberKnife’s new lung cancer radio spot and remember, if you’ve been diagnosed with lung cancer, talk to your doctor about all your treatment options. It’s Your Lungs. Your Cancer. Your Choice.

New Jersey CyberKnife Wins Award of Excellence

New Jersey CyberKnife recently won the Award of Excellence at Alliance Oncology’s 2017 Division Meeting. The annual meeting was held April 12 – 14 at the Sheraton Grand in downtown Nashville, Tennessee. The Award of Excellence is bestowed to the top radiation oncology center in the company and was presented by the Senior Vice President

SBRT Offers Curative Option for Lung Cancer Patients Age 80 and Older

According to research presented at the recent Multidisciplinary Thoracic Cancers Symposium, patients in their eighties and nineties who have early stage lung cancer but cannot undergo an operation can be treated safely and effectively with stereotactic body radiation therapy (SBRT).  The advanced form of radiation therapy was well tolerated among this relatively understudied elderly population,

Understanding Clinical Trials

The future of cancer treatment has never been so promising.  Many advances in cancer treatments are being announced every day and even more treatment options that have the potential to improve the health of cancer patients are currently in development in medical facilities across the country.  As part of the development and approval process, it

SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

According to research presented at the recent 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), high dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity, and excellent cancer control rates.  The Cyberknife at New Jersey Cyberknife delivers SBRT.  Although

Screening Strategy May Predict Lethal Prostate Cancer Later in Life

A recent study found that mid-life prostate-specific antigen (PSA) levels predict who will be more likely to develop lethal prostate cancer.  Investigators from Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health found that measuring PSA levels in younger men (between the ages of 40 and 59) could accurately predict future

New Decision Aids Support Shared Decision Making for Lung Cancer Screening

According to the American Cancer Society’s Cancer Facts & Figures 2016 report, almost 4,000 people will die from lung cancer in New Jersey this year.  One way to lower this number is by increasing the number of lung cancer screenings.  For some adults, annual lung cancer screening could lead to an early diagnosis and life-saving

Study Says Lung Cancer Survival Increases Sharply If Caught Early

According to a recent study in England, increased screening to identify and monitor people at high risk for lung cancer could increase their chance for five-year survival by nearly three-quarters.  Researchers at the University of Liverpool suggest leaders in Britain set up a national screening program to catch more lung cancer earlier, with the hope

Managing Cancer as a Chronic Illness

June is National Cancer Survivor Month.  It is a month dedicated to celebrating and recognizing those who have survived cancer, an inspiration for those recently diagnosed, a gathering of support for families, and an outreach to the community.   According to the Centers for Disease Control and Prevention (CDC), the leading national public health institute

Brain Tumors

May is National Brain Tumor Awareness Month.  According to the National Brain Tumor Society, who is committed to improving the lives of all those affected by brain tumors, more than 69,000 Americans will be diagnosed with a primary brain tumor this year.  A brain tumor is an abnormal growth of tissue in the brain or

Stereotactic Body Radiation Therapy Shows 98 Percent Prostate Cancer Cure

According to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center, a five-year study shows that stereotactic body radiation therapy (SBRT), which can be administered with the CyberKnife® Robotic Radiosurgery System, offers a higher cure rate for prostate cancer than more traditional approaches.  The study, the first trial to publish five-year results

Turning the Tide Against Lung Cancer

In a recent blog, Harold Wimmer, National President and CEO of the American Lung Association, said that 2015 was a game changing year for lung cancer.  His announcement is timely and significant because according to the Centers for Disease Control and Prevention, lung cancer is the leading cancer killer in both men and women in

Do These Three Things to Help Prevent Cancer

If your New Year’s resolution to get fit and healthy is already losing steam, February, which is National Cancer Prevention Month, is a great time to give yourself a second chance.  Renew your efforts to make healthier choices by learning what you can do to help reduce your cancer risk.  The Centers for Disease Control

November is National Lung Cancer Awareness Month

November is officially Lung Cancer Awareness Month.  The event started back in 1995 as Lung Cancer Awareness Day.  As the lung cancer community and the lung cancer movement grew, the awareness activities increased and the day matured into Lung Cancer Awareness Month.  During the month, people throughout the country come together to support the lung

Rajesh Iyer, M.D. Receives Top Doctor Honor

Dr. Rajesh Iyer, Radiation Oncologist at New Jersey CyberKnife and Chairman of Radiation Oncology at Community Medical Center, has been named a 2015 Top Doctor from New Jersey Monthly magazine.  The annual list of New Jersey’s top doctors was announced in the November issue of the publication.  To determine the list of winners, New Jersey

Prostate Cancer Predictors: An Overview of Findings from Recent Study

A 2015 study published in the journal Prostate shows prostate cancer incidence among distant relatives on both sides of a man’s family can help predict whether he will develop the disease.  According to study author Lisa Cannon-Albright, “Family history is a substantial risk factor for prostate cancer.  But typically, a clinician will ask a patient

September is National Prostate Cancer Awareness Month

National Prostate Cancer Awareness Month is observed every September in the United States by health experts and advocates, and individuals concerned with men’s prostate health.  Designating a month for the disease serves the purpose of increasing public awareness of the importance of prostate health and screenings, educating about risk factors and symptoms, and advocating for

New Jersey CyberKnife Proudly Supports the Radiosurgical Research Institute

The Radiosurgical Research Institute (RRI), a 501c3 public charity, is the only independent medical research organization committed to improving the outcomes of cancer patients treated with radiosurgery.  Its mission is to advance radiosurgery as a cancer treatment through innovation, education, and quality research in collaboration with treatment centers around the world.   Before RRI, radiosurgical

The National Comprehensive Cancer Network® Supports SBRT for Prostate Cancer

The National Comprehensive Cancer Network recently updated their patient guide that supports stereotactic body radiation therapy (SBRT) for prostate cancer.  The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 26 of the world’s leading cancer centers, is dedicated to improving the quality, efficiency, and effectiveness of care for patients with cancer.   NCCN aims

Presentation: What You Need to Know about Pancreatic Cancer

The American Cancer Society predicts more than 48,000 people will be diagnosed with pancreatic cancer this year. As one of the most diffcult diseases to diagnose, pancreatic cancer symptoms aren’t usually displayed until the disease is at an advanced stage.  View our presentation below to learn more about pancreatic cancer and its treatment options.   This

When Cancer Spreads: Get the Facts on Metastatic Lung Cancer

Metastatic cancer occurs when cancerous cells spread from a primary cancer site to other parts of the body. When a cancerous tumor is found in another part of the body, that tumor is considered metastatic from the original tumor. For example, lung cancer that spreads to the liver is considered metastatic lung cancer with liver

Top 5 Benefits of CyberKnife

New Jersey CyberKnife treats various types of malignant and benign tumors with a specialized form of radiation therapy called stereotactic body radiation therapy. This treatment is delivered with advanced CyberKnife® technology, a state-of-the-art system that treats tumors with tightly controlled, high-dose radiation precisely targeted to the size and shape of the tumor. Treatment with CyberKnife

Cancer Recurrence: CyberKnife Advantages When Cancer Comes Back

When faced with a cancer recurrence, it’s normal for patients to feel shock and distress. Patients with recurrent cancer often face the challenge of choosing a treatment option that will have the ability to target a new or previously treated area with radiation while having minimal side effects. Thanks to technological advancements in the cancer

Dr. David D'Ambrosio Talks CyberKnife on Local Radio

New Jersey CyberKnife Medical Director Dr. David D’Ambrosio recently visited hosts Joel Markel and Marianne Levy of the Preferred Company radio show to discuss CyberKnife and its benefits for patients. Watch the video below to see Dr. D’Ambrosio in the studio discussing CyberKnife treatment. For more information, contact us. This is not intended as medical

New Jersey CyberKnife Hospital Partner Reaccredited by Commission on Cancer

The J. Phillip Citta Regional Cancer Center at Community Medical Center was recently reaccredited by the Commission on Cancer, achieving the Gold Standard of Care recognition. Pictured at right, New Jersey CyberKnife Medical Director Dr. David D’Ambrosio spoke to hospital leadership and employees at a special celebration held to honor the reaccreditation. “This speaks to

Halloween at New Jersey CyberKnife

Our staff sure know how to have fun and bring smiles to our patients and their loved ones! A few members of our patient care team dressed up as characters from the Wizard of Oz for Halloween. Pictured with our CyberKnife system from left to right are radiation therapists Marilyn Clayton and Maureen Engle, along

Metastatic Cancer: When Breast Cancer Spreads to the Brain

As the second-most diagnosed cancer in women in the U.S., it’s tough to find someone who hasn’t been impacted by breast cancer. When breast cancer is discovered after it starts causing symptoms, the cancer is likely to have advanced and spread beyond the confines of the breast. Many women may be unaware that breast cancer

New Jersey CyberKnife Recognizes Trigeminal Neuralgia Awareness Day

Sometimes described as the most excruciating pain a person can experience, trigeminal neuralgia is a debilitating facial nerve disorder many have never heard of. But for the 12 out of every 100,000 people per year affected by it, the condition can make living a normal life agonizing and unbearable. October 7 is recognized as Trigeminal

Stereotactic Body Radiation Therapy and Metastatic Spinal Tumors: A Research Study

Stereotactic body radiation therapy (SBRT) can serve as a nonsurgical form of treatment to relieve pain associated with spinal tumors. In a recent study titled, “Palliative Strategies for the Management of Primary and Metastatic Spinal Tumors,” researchers examined the methods of treatment for spinal tumor patients who experienced discomfort. Published in the April 2014 issue

Benign Brain Tumors: Top Benefits of CyberKnife Treatment

Although not necessarily fatal, benign brain tumors can pose issues for patients, particularly when a tumor begins to cause symptoms. Patients may experience fatigue, weakness, memory loss, vision problems and seizures, among other symptoms. Common types of benign brain tumors include meningiomas, acoustic neuromas and pituitary adenomas. Patients who are diagnosed with these types of

Barnabas Health Offers Free High-Risk Lung Cancer Screening

New Jersey CyberKnife’s hospital partner will offer free lung cancer screenings on Wednesday, September 17. Learn more about the event and criteria to participate below.   This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed

Wellpoint Anthem Updates Policy to Include Coverage of SBRT for Prostate Cancer

Wellpoint Anthem Blue Cross Blue Shield, the second largest commercial payer in the United States, recently announced that it has updated its SRS/SBRT policy to cover treatment for early stage prostate cancer. Stereotactic body radiation therapy, or SBRT, is a powerful, noninvasive treatment approach that targets radiation beams to match the size and shape of

CyberKnife Treatment for Spinal Tumors

For patients diagnosed with spinal tumors, CyberKnife® treatment offers an important nonsurgical alternative for those who are unable or unwilling to undergo surgery. Some patients may have tumors located near critical structures such as the spinal cord and require a noninvasive treatment that offers precision and minimal radiation exposure to surrounding tissue and critical anatomy.

New Jersey CyberKnife Commemorates Three Years of Service

July marks an important milestone at New Jersey CyberKnife as we complete three years of service at Community Medical Center in Toms River. Since opening in 2011, our center’s experienced physicians and staff have treated more than 460 patients from Ocean County and neighboring communities using advanced CyberKnife® technology. With more than 20 years of

Benefits of Stereotactic Radiosurgery for Brain Tumor Patients

There are more than 120 types of brain tumors, according to the American Brain Tumor Association. New Jersey CyberKnife treats brain tumors and metastatic brain lesions with stereotactic radiosurgery (SRS). Treatment is delivered by CyberKnife® technology, providing an important alternative for patients who are not candidates for surgery or seek a noninvasive treatment option. Unlike

New Jersey CyberKnife Neurosurgeon Profiled in MD News

At New Jersey CyberKnife, we are proud of the exceptional care and dedication our physicians provide to our patients. The newest member of our team is Dr. John Lipani, a board-certified neurosurgeon and the founding director of Princeton Neurological Surgery and the JD Lipani Radiosurgery Institute. Having treated more than 3,500 brain and spinal tumor

Men's Health Month: A Closer Look at Prostate Cancer

June is Men’s Health Month. Celebrated each year to coincide with Father’s Day, this time is dedicated to raising awareness of health problems men may encounter through health education, fundraising and advocacy efforts promoting early detection and treatment of disease. Among the most prevalent men’s health issues is prostate cancer. The prostate is a walnut-shaped

Prostate Cancer Treatment Update: 2014 NCCN Guidelines

The National Comprehensive Cancer Network® (NCCN) recently updated its NCCN Clinical Practice Guidelines in Oncology® to include stereotactic body radiation therapy (SBRT) as a treatment option for prostate cancer. SBRT for prostate cancer involves five or fewer treatment sessions, minimizing disruption to men’s normal routines and lifestyles. Read more about the NCCN and their updated

Prostate Cancer: Early Detection Guidelines

According to the Prostate Cancer Foundation, prostate cancer is typically slow growing, often causing no symptoms until it reaches a more advanced stage. Once the disease begins to grow more rapidly or spreads outside the prostate, it can become a larger health problem. This aggressive type of prostate cancer can occur at any age, though

Treatment Options for Prostate Cancer

According to the American Cancer Society, more than 7,000 New Jersey men will be diagnosed with prostate cancer this year. The appropriate treatment option can vary greatly depending on a number of factors including the stage, grade of the tumor, age, health and lifestyle of the patient. New Jersey CyberKnife treats prostate cancer with stereotactic

Video: Medical Director Explains CyberKnife Treatment

CyberKnife® offers patients many advantages, including fewer treatments and side effects. Learn more from our Medical Director Dr. David D’Ambrosio as he discusses the benefits of CyberKnife treatment in the video below. Wondering if you may be a candidate for CyberKnife treatment? Contact us for more information. This is not intended as medical advice to replace the

Event Recap: Colon Cancer Awareness Health Fair

We are proud to join our partner hospital, Community Medical Center, in the fight against colon cancer. In recognition of Colon Cancer Awareness Month in March, our team attended the 10th Annual Colorectal Cancer Awareness Fair on March 11, held in the outpatient lobby of the hospital. Topics addressed at the event included prevention strategies

U.S. Preventive Services Task Force Recommends CT Lung Cancer Screening

The U.S. Preventive Services Task Force (USPSTF) recently released a recommendation in favor of CT lung cancer screening for long-term smokers. Though still pending finalization, the recommendation applies to current and heavy smokers between 55 and 79 and could be a huge step in diagnosing high-risk patients sooner. The U.S. Preventive Services Task Force is

Spotlight On: Pancreatic Cancer

As one of the most rapidly spreading diseases, pancreatic cancer is difficult to diagnose because patients usually don’t display symptoms until the cancer has progressed and spread to other parts of the body. Common early symptoms include loss of appetite, mild weight loss and mild discomfort in the upper abdomen or occasionally in the middle-back.

Day in the Life: Radiation Therapist

Marilynn Clayton is a Certified Radiation Therapist at our center and has more than 30 years of experience in radiation oncology. As a radiation therapist, she plays a key role in ensuring patient comfort and safety during treatment. Read more about her role as a radiation therapist: What are your major tasks each morning? I

Lung Cancer Awareness Month

Lung Cancer Awareness Month is celebrated each November to raise awareness for the second most common cancer in both men and women. The American Cancer Society estimates 5,960 new cases of lung cancer will be diagnosed in New Jersey this year. Below are a few ways to support the fight against lung cancer: Shine a

CyberKnife: What Does It Treat?

Lung tumors, prostate cancer, and brain tumors are among our center’s most frequently treated diseases, yet the CyberKnife® can also treat other diseases through stereotactic body radiation therapy. Arteriovenous Malformation (AVM): AVMs are abnormal connections between arteries and veins that commonly occur in the brain and spine. Blood typically enters the brain through arteries, moves

Liver Cancer Awareness Month: Facts and Treatment Options

October is Liver Cancer Awareness Month and for those who have been diagnosed or have loved ones facing a diagnosis, it’s important to understand the disease and gather information on treatment options. Characterized by symptoms like abdominal pain, anemia and weight loss, most primary malignant liver cancers are classified as hepatocellular carcinoma, or hepatomas. Treatment

New Jersey CyberKnife Shares Advancements in Research, Prostate Cancer Treatment

As New Jersey CyberKnife collaborates with the University of Pittsburgh to offer an ongoing clinical trial examining stereotactic body radiation therapy (SBRT) for prostate cancer treatment, the center’s medical director, Dr. David D’Ambrosio, is spearheading an analysis of national data on CyberKnife SBRT treatment outcomes and plans to publish his findings. “The research our physician

Spotlight On: Trigeminal Neuralgia

Though primarily used to treat benign and malignant tumors, stereotactic radiosurgery can also treat additional medical conditions, including a rare nerve disorder, trigeminal neuralgia (TN). Excruciating facial pain triggered by everyday activities such as chewing, talking or swallowing characterizes the debilitating condition. TN can often be mistaken for a dental problem, since the disorder usually

Profiles in CyberKnife Treatment: Role of the CyberKnife Nurse

From the initial consultation with our treatment team to follow-up appointments with your CyberKnife®Êphysician, the CyberKnife nurse works to address the needs and concerns of the patient. The CyberKnife nurse provides clinical support and care coordination for patients. This includes assisting the CyberKnife radiation oncologist during patient consultation, educating patients and families in preparation for

Prostate Cancer Awareness Month

This week marks the beginning of Prostate Cancer Awareness Month, which is dedicated to raising awareness, advocating for research and educating men on how to maintain their prostate health. Here’s how you and your loved ones can participate in Prostate Cancer Awareness Month: Be informed. Prostate cancer is the second most common cancer in American

Our Hospital Partner: Community Medical Center

Community Medical Center is New Jersey’s largest non-teaching hospital and Ocean County’s largest health care facility. The hospital, opened in 1961, is an affiliate of Barnabas Health and cares for more than 255,000 patients annually. Community Medical Center is committed to serving the community through high quality health care and ensuring its physicians stay on

Profiles in CyberKnife Treatment: Role of the Medical Physicist

At New Jersey CyberKnife, medical physicists play a key role in the patient treatment process, working closely with other members of the treatment team to support imaging, treatment planning and quality assurance testing of our CyberKnife® technology and its components. Our physics team develops a customized treatment plan that will deliver the radiation dose prescribed

What is Metastatic Cancer?

Metastatic cancer occurs when cancerous cells spread from a primary cancer site to other parts of the body. Despite spreading to another location within the body, the cancer is considered an extension of the original tumor. For example, lung cancer that spreads to the liver is considered metastatic lung cancer. Metastatic cancers are difficult to

New Jersey CyberKnife Reaches Two-Year Milestone at Community Medical Center, Highlights Achievements in Brain Tumor Treatment

Celebrating two years at Community Medical Center this month, New Jersey CyberKnifeÊhas treated nearly 300 patients from Ocean County and neighboring areas using advanced CyberKnife® technology. The center opened in 2011 offering treatment for malignant and benign tumors throughout the body with a noninvasive procedure called stereotactic radiosurgery. As the second most frequently treated disease

The Stages of Cancer

When someone is diagnosed with cancer, determining the stage of the cancer is an important next step. Staging describes the extent or severity of a person’s cancer, which helps doctors determine the best course of treatment and a prognosis. Common Staging Procedures and Types: The most common staging is TNM, which designates three aspects of

Celebrate Men's Health Month in June

June is Men’s Health Month! This time is dedicated to raising awareness of preventable health problems men may encounter through health education, fundraising and advocacy efforts promoting early detection and treatment of disease. Here’s how you can get involved: Wear blue. The Men’s Health Network created the initiative to support men’s health efforts. Learn more

Prostate Cancer Series: Understanding the Treatment Process

New Jersey CyberKnife is committed to helping patients understand their diagnosis and the treatment process. The video below provides an overview of how CyberKnife® treats prostate cancer and the benefits of using this advanced technology. This post is part of a series dedicated to addressing one of the most important health issues facing men today.

Spotlight On: Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is a dynamic organization committed to funding cutting-edge prostate cancer research. Since 1993, the PCF has funded more than 1,600 programs at nearly 200 research facilities around the world. In 2012, the organization raised a record $47 million and expanded their research programs to China. Each year, the PCF partners

From the Doc: Benefits of CyberKnife for Prostate Cancer Patients

Find out how stereotactic body radiation therapy (SBRT) with CyberKnife® can benefit prostate cancer patients. Below are some advantages from our medical director Dr. David D’Ambrosio. What sets CyberKnife apart from other treatment options?CyberKnife offers patients a noninvasive treatment option that doesn’t impede on their lifestyle. CyberKnife can treat prostate cancer patients in five or

Research Notes: High-dose Stereotactic Body Radiotherapy Effective, Quick for Localized Prostate Cancer

In a study presented at the annual meeting of the American Society of Radiation Oncology, researchers found that men with organ-confined prostate cancer can be treated successfully with stereotactic body radiation therapy. The five-year, multi-center study evaluated low-risk, intermediate-risk and high-risk patients for up to four years following treatment. At the five-year mark, the relapse-free

New Jersey CyberKnife Medical Director Awarded Physician Excellence in Caring Award

Medical Director Dr. David D’Ambrosio was awarded the Physician Excellence in Caring Award by New Jersey CyberKnife hospital partner Community Medical Center for his commitment to enhancing patient care. He was honored not only for the lifelong bonds he develops with his patients, but also for his advocacy for access to state-of-the-art technology and willingness

Prostate Cancer Series: What is Prostate Cancer?

Prostate cancer is a disease specific to men and develops in the prostate – a walnut-shaped organ in a man’s lower abdomen that controls the flow of urine and semen through the reproductive system. According to the Prostate Cancer Foundation, prostate cancer is typically a slow-growing tumor, often causing no symptoms until it reaches a

Get to Know: New Jersey CyberKnife Medical Director Dr. David D'Ambrosio

Our medical director, Dr. David D’Ambrosio, has a longstanding commitment to clinical research and stereotactic radiosurgery for cancer treatment. He has given a number of national and international presentations at meetings of the American Society for Therapeutic Radiology and Oncology (ASTRO) and the American Radium Society (ARS). He has also published several peer-reviewed research papers

Spotlight On: Prostate Cancer

New Jersey CyberKnife has opened a clinical trial in collaboration with the University of Pittsburgh to evaluate stereotactic body radiation therapy for low, intermediate and high-risk prostate cancer patients. Results from these trials will add to the body of clinical research examining stereotactic body radiation therapy for prostate cancer and will help doctors analyze effects and

Spotlight on: Brain Tumors

According to the American Cancer Society, brain tumors account for one in every 100 cancers diagnosed annually in the United States. CyberKnife® stereotactic radiosurgery is an advanced treatment option for brain tumors, providing an important nonsurgical alternative for patients. Below is a brief overview of brain tumors, incidence rates and treatment options.      

Spotlight On: The CyberKnife Treatment Process

In the fight against cancer, CyberKnife® provides an important alternative for patients seeking a nonsurgical option with shorter treatment times, fewer side effects and a more rapid recovery. Our center uses a team approach to patient care in which physicians and other team members collaborate to develop a customized CyberKnife treatment plan to best suit

Stereotactic Body Radiation Therapy for Prostate Cancer Provides Cancer-Free Results

Researchers at the 54th Annual American Society for Radiation Oncology meeting presented findings showing men with organ-confined prostate cancer can be treated successfully with stereotactic body radiation therapy. To date, the study is the most extensive of its kind, with data from more than 1,000 patients treated for prostate cancer using the CyberKnife® technology. Low-risk,

Lung Cancer Awareness Important for Prevention, Early Detection

As the second-most common cancer in both men and women, lung cancer is responsible for the majority of cancer-related deaths. The American Cancer Society estimates more than 160,000 people will lose their battle with lung cancer this year, accounting for more victims than breast, prostate, colon and pancreatic cancers combined. In recognition of National Lung

Breast Cancer Awareness: Treatment Options When Breast Cancer Spreads

As the second-most diagnosed cancer in women in the U.S., it’s tough to find someone who hasn’t been impacted by breast cancer in some way. The American Cancer Society estimates 230,480 women will be diagnosed with invasive breast cancer this year. Most breast cancers are found by routine screening mammograms. If breast cancer is discovered

New Jersey CyberKnife Physician Team Speaks with WOBM-AM at

In recognition of National Breast Cancer Awareness Month, New Jersey CyberKnife hospital partner Community Medical Center teamed up with 92.7 WOBM for a live broadcast of “Pretty in Pink” 2012. WOBM personalities Shawn Michaels and Sue Moll did a live broadcast at the hospital in an effort to raise awareness and support for the fight

New Jersey CyberKnife treats Trigeminal Neuralgia Patients

New Jersey CyberKnife is currently treating trigeminal neuralgia patients noninvasively using CyberKnife technology. Trigeminal neuralgia is a painfully debilitating neuropathic disorder. Commonly referred to as TN, the condition is a disorder of the trigeminal, or fifth cranial, nerve that controls sensation in the face. TN patients experience episodes of intense, electroshock-like pain on either side

Prostate Cancer Treatment Advancements Improve Survivorship

One in six men will face a prostate cancer diagnosis in his lifetime, totaling to 240,000 new cases this year as estimated by the American Cancer Society. Fortunately, advancements in cancer treatment have allowed nearly eight times as many men to count themselves as survivors of the pervasive disease. September is National Prostate Cancer Awareness

New Jersey CyberKnife Celebrates One Year at Community Medical Center

New Jersey CyberKnife opened in July 2011 as part of the J. Phillip Citta Regional Cancer Center at Community Medical Center and was the first in Ocean County to offer CyberKnife treatment. One year later, New Jersey CyberKnife reflects on several milestones from its first year of providing cancer care for patients throughout Ocean County

New Jersey CyberKnife Shares Men's Health Awareness Tips

June is dedicated to raising awareness and prevention of the preventable health problems men face while encouraging men to seek regular medical advice and early treatment for disease or injury. One of the common health threats to men is prostate cancer. In 2012, the American Cancer Society estimates about 241,740 new diagnoses of prostate cancer.

New Jersey CyberKnife discusses treatment options during Brain Tumor Awareness Month

May is National Brain Tumor Awareness Month. Since its establishment in 2008, community organizations and support groups honor this month with increased efforts to raise awareness of brain tumors, increase funding for research and educate the public on symptoms and treatment options.  The Central Brain Tumor Registry estimates 66,290 new cases of primary non–malignant and

Medical Director Gives Talk on Prostate Cancer Treatment Options

New Jersey CyberKnife medical director, Dr. David D’Ambrosio was honored to speak to the Silver Ridge Men’s Club on April 11. Dr. D’Ambrosio spoke with the group about risk factors, symptoms and treatment options of prostate cancer. A big thanks to the Men’s Club for hosting!            

New Jersey CyberKnife Highlights Healthy Living for National Cancer Control Month

In support of April as Cancer Control Month, New Jersey CyberKnife is encouraging local residents to use a proactive approach to a healthy lifestyle. Cancer Control Month highlights the progress in fighting cancer and increases awareness of who is at risk. The initiatives of Cancer Control Month seek to encourage healthy lifestyles, promote cancer screening,